BridgeMD
New treatment option for Prostate Cancer
Official title The Man Van Project
ClinicalTrials.gov ID: NCT06357416
What this study is testing
- What it's testing
- National Health Service (NHS) England has commissioned The Royal Marsden Hospital NHS Foundation Trust to run a novel mobile clinical outreach service called 'Man Van' with the aim of enabling male patients' easy access to care at the site of their work and in their communities. The initial focus of this new standard of care clinic is to access workplaces with large manual workforces where large scale working from home is not possible.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- Patients are eligible to be included in the research study if they are eligible to access the Man Van mobile outreach clinic, which is a novel...
You likely can't join if
- have been designed to be as broad as possible, in order to include data from as many patients using the Man Van clinical service as possible. As the...
- Participating in the linked Man Van mobile outreach clinic
- Age ≥45 years
- Male (The initial pilot study had a age criteria of ≥18 years, but this was amended). MV-POCT Inclusion Criteria: Any patient having a PSA and/or an...
- Aged \> 18 and over (on date of invitation to participate)
- Works for healthcare organisation, other stakeholder or professional or potential man van patient who was not seen or relative of a Man Van...
See the full eligibility criteria
- Patients are eligible to be included in the research study if they are eligible to access the Man Van mobile outreach clinic, which is a novel clinical service delivered by The Royal Marsden Hospital NHS Foundation...
- have been designed to be as broad as possible, in order to include data from as many patients using the Man Van clinical service as possible. As the primary purpose of the Man Van mobile outreach clinic is to screen for...
- Participating in the linked Man Van mobile outreach clinic
- Age ≥45 years
- Male (The initial pilot study had a age criteria of ≥18 years, but this was amended). MV-POCT Inclusion Criteria: Any patient having a PSA and/or an HbA1c test as part of a Man Van work up, or via the our rapid...
- Aged \> 18 and over (on date of invitation to participate)
- Works for healthcare organisation, other stakeholder or professional or potential man van patient who was not seen or relative of a Man Van patient/potential patient Exclusion criteria:
- Man van patient who has attended appointment MV-TPP Inclusion criteria: Healthcare Professionals
- Aged \> 18 and over (on date of invitation to participate)
- Speaks English
- Works within the UK
- Profession: GPs, Practice Staff (Nurses, Physician Assistants and Associates
- Healthcare assistants)
- Experienced in adopting new tests and guidelines into practice.
- Experienced in detecting, managing, and referring symptoms and asymptomatic patients with symptoms of prostate, pancreatic, GI cancer and/or are at an increased risk of developing these cancers. Patients
- Aged \> 18 and over (on date of invitation to participate)
- Speaks English
- Lives in the UK
- Patients with direct and in-direct experience with prostate, pancreatic, GI cancers.
- Patients at an increased risk of developing prostate, pancreatic, GI cancer in accordance with known risk factors, which includes age, smoking, being overweight or obese, family history and genetic factors...
- Aged \> 18 and over (on date of invitation to participate)
- Speak English
- Works within the UK
- Professions: medical devices and biomedical researchers, scientists, representatives for major regulatory and funding bodies
- Knowledgeable of Early Detection initiatives (tests, outreach programes) Exclusion criteria: GPs
- Individuals who are unwilling to take part in the study.
- Individuals with no experience in adopting new cancer tests and guidelines into practice.
- Individuals with no experience in in detecting, managing, and referring patients with symptoms of cancer and/or are at an increased risk of developing prostate, pancreatic, GI cancer.
- Individuals who do not adequately understand verbal explanations or written information in English. Patients Individuals who are unwilling to take part in the study.
- Individuals who do not adequately understand verbal explanations or written information in English.
- Unable to provide written and verbal consent.
- No direct or indirect lived experience with prostate, pancreatic, GI cancers. Non-clinical key stakeholders/professionals Individuals who are unwilling to take part in the study Individuals who are not familiar with...
- Individuals who do not adequately understand verbal explanations or written information in English
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.